USA Elite System™ MRO™-20 Rigid Percutaneous Nephroscopes
Navigation Links
USA Elite System™ MRO™-20 Rigid Percutaneous Nephroscopes
| Products | USA Elite System™ MRO™-20 Rigid Percutaneous Nephroscopes |
| Company | GYRUS ACMI |
| Item | USA Elite System™ MRO™-20 Rigid Percutaneous Nephroscopes |
| Features |
|
| Description | ACMITM MRO™-2004 and MRO™-2005 Rigid Percutaneous Nephroscopes combine small diameter convenience and large working throughput capacity with proven MRO performance. These nephroscopes provide large operating channels with small size sheaths. The MRO™-20 sheaths have rotating irrigation ports for easy positioning during percutaneous procedures. The molded body design has offset optics for comfortable viewing, and the Snap-In Snap-Out® locking mechanism assures quick, secure changes during procedures. |
| Info | GYRUS ACMI Customer Service: (508) 804-2600 Web site: http://www.acmicorp.com |
Related medicine products :
1. Vasculight Elite
2. Vasoseal Elite
3. NIR Elite OTW Stent System
4. NIR Elite Monorail Stent System
5. Sandman Elite
6. The Elite™ Premium Shoulder Instrument Systems
7. Apogee Elite Two-in-One Laser System
8. Elite System II
9. USA Series DUR-8 Elite Durable Flexible Ureteroscope System with Primary and Secondary Deflection
10. USA Elite System™ Rotating Continuous Flow Resectoscopes
11. USA Elite System™ & USA Series™ Grooved VaporTome® Vaporization Electrode
Breaking Medicine News(10 mins):Health News:Obesity and Inactivity -- The Biggest Threat to the Nation's Health 2Health News:Obesity and Inactivity -- The Biggest Threat to the Nation's Health 3Health News:Unanimous Vote Creates Largest RN Union in U.S. History 2Health News:Senator Ben Nelson Puts U.S. Bishops' Interests Ahead of Americans' Healthcare Needs 2Health News:Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765 2Health News:Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765 3Health News:Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765 4Health News:Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765 5Health News:Pitt study suggests craving hinders comprehension without your realizing it 2
[1] Obesity and Inactivity -- The Biggest Threat to the Nation's Health[0] Unanimous Vote Creates Largest RN Union in U.S. History[1] Senator Ben Nelson Puts U.S. Bishops' Interests Ahead of Americans' Healthcare Needs[1] Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765[0] Pitt study suggests craving hinders comprehension without your realizing it
Other Medicine News:Health News:Shaklee Helps Create Healthier Lives With Its Infinite Possibilities Tour 2Health News:Pelosi Statement on Reintroduction of the Early Treatment for HIV Act 2Health News:With the Economy Down, Vasectomy Rates Are Up 2
Shaklee Helps Create Healthier Lives With Its Infinite Possibilities TourSouthern California Veterinary Hospital Rescued From the Scrap HeapPelosi Statement on Reintroduction of the Early Treatment for HIV ActWith the Economy Down, Vasectomy Rates Are UpAHIMA Applauds Selection of Dr. Blumenthal to Head ONCMalnutrition risk underappreciated in laryngeal cancer patients
Breaking Medicine Technology:CareFusion Announces Six New Pyxis(R) Technologies at the ASHP Midyear Clinical Meeting and Exhibition 2CareFusion Announces Six New Pyxis(R) Technologies at the ASHP Midyear Clinical Meeting and Exhibition 3The Epilepsy Research Foundation and Milken Family Foundation Announce Prestigious Translational Research Grants for Two Pioneering Epilepsy Therapies 2The Epilepsy Research Foundation and Milken Family Foundation Announce Prestigious Translational Research Grants for Two Pioneering Epilepsy Therapies 3The Epilepsy Research Foundation and Milken Family Foundation Announce Prestigious Translational Research Grants for Two Pioneering Epilepsy Therapies 4The Epilepsy Research Foundation and Milken Family Foundation Announce Prestigious Translational Research Grants for Two Pioneering Epilepsy Therapies 5Baxa Features DoseEdge(TM) Pharmacy Workflow Manager at the ASHP Midyear Clinical Meeting 2Baxa Features DoseEdge(TM) Pharmacy Workflow Manager at the ASHP Midyear Clinical Meeting 3Poorer Outcomes After Off Pump Bypass Surgery 60716 1Poorer Outcomes After Off Pump Bypass Surgery 60716 2Poorer Outcomes After Off Pump Bypass Surgery 60716 3Nationally Known Psychotherapist Dr Robi Ludwig Joins Qualsecs Wholly Owned Subsidiary VitaminSpice 60711 1Nationally Known Psychotherapist Dr Robi Ludwig Joins Qualsecs Wholly Owned Subsidiary VitaminSpice 60711 2Kendle Announces Third Quarter 2009 Results 60706 1Kendle Announces Third Quarter 2009 Results 60706 2Kendle Announces Third Quarter 2009 Results 60706 3Kendle Announces Third Quarter 2009 Results 60706 4Kendle Announces Third Quarter 2009 Results 60706 5Kendle Announces Third Quarter 2009 Results 60706 6Kendle Announces Third Quarter 2009 Results 60706 7Kendle Announces Third Quarter 2009 Results 60706 8Kendle Announces Third Quarter 2009 Results 60706 9Kendle Announces Third Quarter 2009 Results 60706 10
[0] CareFusion Announces Six New Pyxis(R) Technologies at the ASHP Midyear Clinical Meeting and Exhibition[0] The Epilepsy Research Foundation and Milken Family Foundation Announce Prestigious Translational Research Grants for Two Pioneering Epilepsy Therapies[0] Baxa Features DoseEdge(TM) Pharmacy Workflow Manager at the ASHP Midyear Clinical Meeting
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |